Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
are biochemistry, (bio)-organic chemistry, medicinal chemistry, molecular biology and structural biology. Research in Energy & Sustainability focusses on fundamental aspects of chemical reactions of importance
-
are biochemistry, (bio)-organic chemistry, medicinal chemistry, molecular biology and structural biology. Research in Energy & Sustainability focusses on fundamental aspects of chemical reactions of importance
-
research areas: ‘Chemical Biology’ and ‘Energy & Sustainability’. The institute’s research themes illustrate the central position of chemistry between biology, medicine and physics. The various research
-
allow to interrogate biological systems. Core research areas are biochemistry, (bio)-organic chemistry, medicinal chemistry, molecular biology and structural biology. Research in Energy & Sustainability
-
‘Energy & Sustainability’. The institute’s research themes illustrate the central position of chemistry between biology, medicine and physics. The various research topics carried out within these themes
-
professionally and personally. The department Chemical Engineering and Chemistry is one of the nine departments of Eindhoven University of Technology. It was established in 1957, shortly after the university
-
Position Other academic staff Irène Curie Fellowship No Department(s) Chemical Engineering and Chemistry Reference number V37.7421 Job description Technician on MBO/HBO level for PCB design Engineer
-
) Biomaterials and regenerative medicine, (2) (Bio)artificial organs, (3) Engineered therapeutics. Its mission is: 1. To provide innovative technological solutions to patients suffering from chronic and malignant
-
of holiday hours for full-time employment is 232 hours per calendar year. Department AOT consists of 3 research chairs: (1) Biomaterials and regenerative medicine, (2) (Bio)artificial organs, (3) Engineered
-
scientific concepts in fundamental and translational research underlying the discovery and optimization of drugs, and personalised medicines. We aim to optimise the route to novel drugs that are both